Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The duration for IV therapy to take effect can vary depending on the type of treatment being used and the individual patients condition
Researchers document improved range of motion and reduced pain in animal models. Collagen Synthesis: GHK-Cu-driven increases in collagen production (70% improvement documented in clinical studies) support structural protein remodeling across tissues. Skin Repair and Anti-Aging: The blend targets skin rejuvenation through collagen stimulation, angiogenesis, anti-inflammatory signaling, and cell migration, addressing fine lines, wrinkles, clarity, and tissue density. Gut Barrier Function: BPC-157 and KPV both show potential for epithelial repair and inflammation suppression in gastrointestinal tissues. Cellular Oxidative Balance: GHK-Cus gene expression modulation includes upregulation of antioxidant pathways and DNA repair genes. Side Effects and Safety Profile Individual Component Safety Data BPC-157: Animal studies have consistently found no lethal dose (LD1 not achieved) and no reported acute adverse effects
Pax Medicas next trial for Autism will be in 2024
This product is provided strictly for research purposes
Not all applied product reaches target cells, so formulations include buffer above the minimum effective dose
Clarifying compoundgut microbiota interactions and whether microbial metabolism enhances or limits therapeutic efficacy would strengthen the gutliver axis perspective
US$ 22.67
US$ 29.04
US$ 26.49
US$ 20.13
